CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population

Area of Science:

• Immunogenetics
• Rheumatology
• Genetic Epidemiology

Background:

• Behçet's disease (BD) pathogenesis involves dysregulated T-helper cell function.
• Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is a key regulator of T-cell activity.
• Genetic variations in CTLA-4 may influence susceptibility to autoimmune diseases like BD.

Purpose of the Study:

• To investigate the association between the CTLA-4 +49A/G polymorphism and Behçet's disease in the Tunisian population.
• To determine if the CTLA-4 +49A/G polymorphism influences disease susceptibility or clinical manifestations in BD patients.

Main Methods:

• Genotyping of 135 Tunisian BD patients and 151 healthy controls for the CTLA-4 +49 A/G polymorphism using polymerase chain reaction.
• Statistical analysis including chi-squared tests, odds ratios, and confidence intervals to compare allele and genotype frequencies.
• Analysis of genotype-phenotype correlations with clinical manifestations of BD.

Main Results:

• A highly significant association was found between the CTLA-4 +49 A allele and BD patients compared to controls (P < 10(-7)).
• The A allele showed a gene dose effect, increasing susceptibility to Behçet's disease.
• The A allele was significantly more prevalent in male BD patients (76.3%) than in females (62%) (P = 0.014), indicating a stronger effect in males.
• No correlation was observed between the CTLA-4 +49A/G genotype and specific clinical features of BD.

Conclusions:

• The CTLA-4 +49A/G polymorphism, specifically the A allele, is a significant genetic risk factor for Behçet's disease in the Tunisian population.
• The genetic predisposition conferred by the A allele appears to be stronger in males, suggesting a sex-specific role in BD pathogenesis.
• Further research is warranted to elucidate the functional mechanisms underlying the association between CTLA-4 polymorphism and BD, particularly its sex-dimorphic effects.